A one-year multicenter study of efficacy and safety of a continuous, low- dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging

American Journal of Obstetrics and Gynecology

Volumn 174, Issue 1, 1996, Pages 85-92

  Henriksson, L ^a   Stjernquist, M ^a   Boquist, L ^a   Cedergren, I ^a   Selinus, I ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

estradiol; postmenopause; Urogenital aging; vaginal ring

Indexed keywords

ESTRADIOL; ESTRIOL;

ADULT; AGED; AGING; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PH; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ULCER; UROGENITAL TRACT DISEASE; VAGINA BLEEDING; VAGINA CYTOLOGY; VAGINA DISEASE; VAGINA MUCOSA; VAGINA PESSARY; VAGINA RING;

EID: 0030060290     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(96)70378-2     Document Type: Article

References (9)

1. GM Heimer DE Englund Estriol absorption after long-term vaginal treatment and gastrointestinal absorption as influenced by a meal Acta Obstet Gynecol Scand 63 1984 563 567
2. L Henriksson M Stjernquist L Boquist U Ålander I Selinus A comparative multicenter study of effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy AM J OBSTET GYNECOL 171 1994 624 632
3. P Smith G Heimer M Lindskog U Ulmsten Oestradiol-releasing vaginal ring for treatment of postmenopausal urogenital atrophy Maturitas 16 1993 145 154
4. U Ulmsten N Stormby Evaluation of the urethral mucosa before and after oestrogen treatment in postmenopausal women with a new sampling technique Gynecol Obstet Invest 24 1987 208 211
5. J Hustin J-P Van den Eynde Cytologic evaluation of the effect of various estrogens given in postmenopause Acta Cytol 21 1977 225 228
6. Institute Inc SAS SAS procedures guide, version 6 1990 SAS Institute Inc Cary, North Carolina 705
7. TJA Key MC Pike The dose-effect relationship between “unopposed” oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk Br J Cancer 57 1988 205 212
8. K Boman P Strang T Bäckström U Gerdes U Stendahl Influence of oestrogen on growth of endometrial carcinoma Anticancer Res 10 1990 173 176
9. R Lindgren G Berg H Hammar E Zuccon Hormone replacement therapy and sexuality in a population of Swedish postmenopausal women Acta Obstet Gynecol Scand 72 1993 292 297